📰 Retrospective Study News
Page 5 - Retrospective Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Retrospective Study. Real-time updates on events, politics, business and more.
December 12, 2021
Real-world experience study of more than 3,100 patients demonstrates statistically significant reductions in transfusions, vaso-occlusive crises and hospitalizations in patients treated with... | December 12, 2021
August 14, 2021
Children, its abusive to force kids who struggle to sacrifice for the sake of unsafe adults. like the author, this, too a johns hopkins medical professor and top childrens hospital chief they wrote, do masks reduce covid transmissions in children? believe it or not, we could find only a single retrospective study on the question and its results are conclusive. conversely they argue that widespread masking causes psychological impact and can result until severe acne. increased problems with carbo...
May 25, 2021
Retrospective study on herbal preparation of Anandaiah begins Updated: Updated: A report will be submitted to Central Council for Research in Ayurvedic Sciences Share Article A report will be submitted to Central Council for Research in Ayurvedic Sciences With the herbal preparation made by B. Anandaiah of Krishnapatnam in Nellore district for coronavirus patients triggering a controversy, Sri Venkateswara Ayurvedic College (SVAC) authorities has undertaken a retrospective study on its effica...
February 3, 2021
ABS120, ABS185]. About Hemophilia Hemophilia is a chronic disease that causes longer-than-normal bleeding due to absent or deficient clotting factor in the blood. 4 Hemophilia A is more common than hemophilia B; in 2018, hemophilia A affects about 173,711 people, whereas hemophilia B affects about 34,289 people worldwide. 5 People with hemophilia, working closely with their healthcare professionals, can live healthy lives with proper care and adequate treatment. 6 Treatment regimens typically i...
February 3, 2021
News Category Global Banking & Finance Reviews Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (Takeda) today announced that 14 abstracts from the companys Hematology portfolio and pipeline are b...